SPADA Docs

190 Figure 4. Traditional vs. modern assay development pipeline. Inc/Exc: Inclusivity/Exclusivity.

191 192

4.0 Assay Design

193

194

4.1 Target selection: user defined vs unbiased (in silico)

Traditionally, assay target selection has been an ill-defined process that is strongly influenced 195 by the preferences and experience of individual assay designers. Often, assay targets are selected 196 from lab-specific research interests on specific genes of given pathogens or from known 197 (literature-based), or suspected, virulence factor genes. The resulting assays are then screened 198 (either computationally or “by eye”) for inclusivity and exclusivity using hand-selected 199 sequences. The resulting assays are also often broadly screened computationally against all 200 known sequences (e.g., by using Basic Local Alignment Search Tool ( BLAST ) to identify 201

12